Related references
Note: Only part of the references are listed.Interleukin-1 beta causes synaptic hyperexcitability in multiple sclerosis
Silvia Rossi et al.
ANNALS OF NEUROLOGY (2012)
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Nabila Haji et al.
EXPERIMENTAL NEUROLOGY (2012)
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis
Mariantonietta Caragnano et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Decreased microglial activation in MS patients treated with glatiramer acetate
John N. Ratchford et al.
JOURNAL OF NEUROLOGY (2012)
Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Giancarlo Comi et al.
ANNALS OF NEUROLOGY (2011)
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
Silvia Rossi et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis
Silvia Rossi et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
Rina Aharoni et al.
JOURNAL OF AUTOIMMUNITY (2011)
Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
Refik Pul et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Recent insights into the mechanism of action of glatiramer acetate
Mrinalini Kala et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
Aaron Boster et al.
Therapeutic Advances in Neurological Disorders (2011)
Glatiramer Acetate Attenuates Pro-Inflammatory T Cell Responses but Does Not Directly Protect Neurons from Inflammatory Cell Death
Alexander M. Herrmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis
Diego Centonze et al.
JOURNAL OF NEUROSCIENCE (2009)
The Multifaceted Profile of Activated Microglia
Marina A. Lynch
MOLECULAR NEUROBIOLOGY (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
CD4+CD25+FoxP3+PD1 - regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy
Marina Saresella et al.
FASEB JOURNAL (2008)
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
R. E. Gonsette
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Grey matter pathology in multiple sclerosis
Jeroen J. G. Geurts et al.
LANCET NEUROLOGY (2008)
Neurogenesis and neuroprotection in the CNS - Fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders
Ruth Arnon et al.
MOLECULAR NEUROBIOLOGY (2007)
Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia
Luca Muzio et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
T cell independent mechanism for copolymer-1-induced neuroprotection
Jianuo Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease
Martin S. Weber et al.
NATURE MEDICINE (2007)
Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis
A Sanna et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
R Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate
D Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis
R Aharoni et al.
JOURNAL OF NEUROSCIENCE (2005)
Microorlial cell activation and proliferation precedes the onset of CNS autoimmunity
ED Ponomarev et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3
J Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat
M Blair et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
FL Heppner et al.
NATURE MEDICINE (2005)
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
HJ Kim et al.
JOURNAL OF IMMUNOLOGY (2004)
Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications
R Arnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gr-1+ myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-γ- and nitric oxide-dependent mechanism
M Dupuis et al.
JOURNAL OF IMMUNOLOGY (2003)
Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis
S Chabot et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
T2 hypointensity in the deep gray matter of patients with multiple sclerosis - A quantitative magnetic resonance imaging study
R Bakshi et al.
ARCHIVES OF NEUROLOGY (2002)
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
H Schori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt et al.
NATURE MEDICINE (2000)